II. Indications
III. Dosing
-
Parenteral
- Initial: 1 mg SC/IM/IV over 3-4 minutes
- Repeat: May repeat every 1 hour
- Maximum: 3 mg/day, 6 mg/week, 20 mg/month
- Intranasal Dihydroergotamine (Migranal)
IV. Advantages
- Weaker Vasoconstrictor (less Side Effects)
- No Rebound Headache
V. Adverse Effects
- Retroperitoneal fibrosis
Images: Related links to external sites (from Bing)
Related Studies
dihydroergotamine (on 9/21/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
DIHYDROERGOTAMINE MESYLATE 4 MG/ML NASAL SPRAY | Generic | $147.05 per ml |
Ontology: Dihydroergotamine (C0012291)
Definition (MSH) | A 9,10alpha-dihydro derivative of ERGOTAMINE. It is used as a vasoconstrictor, specifically for the therapy of MIGRAINE DISORDERS. |
Concepts | Pharmacologic Substance (T121) , Organic Chemical (T109) |
MSH | D004087 |
SnomedCT | 363557006, 387267005, 48875009 |
English | Ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'alpha,10alpha)-, 9,10-Dihydroergotamine, Dihydroergotamine [Chemical/Ingredient], Dihydroergotamine product (product), dihydroergotamine, DIHYDROERGOTAMINE, Dihydroergotamine (substance), Dihydroergotamine (product), Dihydroergotamine product, Dihydroergotamine product (substance), Dihydroergotamine |
Swedish | Dihydroergotamin |
Czech | dihydroergotamin |
Finnish | Dihydroergotamiini |
Russian | DIGIDROERGOTAMIN, ДИГИДРОЭРГОТАМИН |
Japanese | ヒポラール, ジヒドロエルゴタミンメシル酸塩, メシル酸ジヒドロエルゴタミン, ハイデルゴット, ジヒドロエルゴタミン, ジヒデルゴット |
Croatian | DIHIDROERGOTAMIN |
Polish | Dihydroergotamina, Dwuhydroergotamina |
Portuguese | Di-Hidroergotamina |
Spanish | dihidroergotamina, producto (producto), dihidroergotamina, producto, dihidroergotamina (sustancia), dihidroergotamina, dihidroergotamina (producto), Dihidroergotamina |
French | Dihydroergotamine |
German | Dihydroergotamin |
Italian | Diidroergotammina |